Early Cytogenetic and Molecular Response During First-Line Treatment of Chronic Myeloid Leukemia in Chronic Phase: Long-Term Implications

類似資料

• Monitoring Molecular Response in Chronic Myeloid Leukemia
  著者:: Cortes, Jorge, 等
  出版事項: (2010)
• Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
  著者:: Quintás-Cardama, Alfonso, 等
  出版事項: (2009)
• The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure
  著者:: Jabbour, Elias, 等
  出版事項: (2013)
• The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients with Chronic Phase Chronic Myeloid Leukemia After Failure to Frontline Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?
  著者:: Cortes, Jorge, 等
  出版事項: (2011)
• Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia
  著者:: Quintás-Cardama, Alfonso, 等
  出版事項: (2009)